SURROBODY-KONJUGATE
European patent · EP2804631 · In force
Register entry
- Publication number
- EP2804631
- Application number
- EP13701560
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jan 18, 2013
- Published
- Nov 26, 2014
- Granted
- Mar 17, 2021
- Protection ends at the latest
- Jan 17, 2033
- Next annual fee due
- Jan 31, 2027
- IPC classes
- A61K 38/05 (2006.01)A61K 31/5383 (2006.01)A61K 47/68 (2017.01)A61P 35/00 (2006.01)
- Priority
- US 201261589272 P 20.01.2012US 201361848379 P 02.01.2013
- PCT application
- PCT/US2013/022308 18.01.2013
- PCT publication
- WO2013/109994 25.07.2013
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Feb 1, 2026
Change
Published in Swissreg on 01.02.2026
- Feb 1, 2025
Change
Published in Swissreg on 01.02.2025
- Feb 1, 2024
Change
Published in Swissreg on 01.02.2024
- Aug 23, 2023
Transferred
- Owner
- i2 Pharmaceuticals, Inc., 4909 Nautilus Court N., Suite 208, Boulder, CO 80301, USA → BioAssets,, LLC, 517 Pine Street, Boulder, CO 80302, USA
- Representative
- MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex
Published in Swissreg on 23.08.2023
- Feb 1, 2023
Change
Published in Swissreg on 01.02.2023
- Aug 9, 2022
Change
Published in Swissreg on 09.08.2022
- Jan 26, 2022
Change
Published in Swissreg on 26.01.2022
- Mar 17, 2021
Granted
Published in Swissreg on 17.03.2021
Parties
Inventor
Atherton, CA 94027, US
Belmont, CA 94002, US
Atherton, CA 94027, US
Atherton, CA 94027, US
Atherton, CA 94027, US
Atherton, CA 94027, US
Atherton, CA 94027, US
Atherton, CA 94027, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.